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Abstract
Background: Mosquito vectors of malaria in Southeast Asia readily feed outdoors making malaria control through indoor
insecticides such as long-lasting insecticidal nets (LLINs) and indoor residual spraying more difficult. Topical insect repellents
may be able to protect users from outdoor biting, thereby providing additional protection above the current best practice
of LLINs.
Methods and Findings: A double blind, household randomised, placebo-controlled trial of insect repellent to reduce
malaria was carried out in southern Lao PDR to determine whether the use of repellent and long-lasting insecticidal nets
(LLINs) could reduce malaria more than LLINs alone. A total of 1,597 households, including 7,979 participants, were recruited
in June 2009 and April 2010. Equal group allocation, stratified by village, was used to randomise 795 households to a 15%
DEET lotion and the remainder were given a placebo lotion. Participants, field staff and data analysts were blinded to the
group assignment until data analysis had been completed. All households received new LLINs. Participants were asked to
apply their lotion to exposed skin every evening and sleep under the LLINs each night. Plasmodium falciparum and P. vivax
cases were actively identified by monthly rapid diagnostic tests. Intention to treat analysis found no effect from the use of
repellent on malaria incidence (hazard ratio: 1.00, 95% CI: 0.99–1.01, p = 0.868). A higher socio-economic score was found to
significantly decrease malaria risk (hazard ratio: 0.72, 95% CI: 0.58–0.90, p = 0.004). Women were also found to have a
reduced risk of infection (hazard ratio: 0.59, 95% CI: 0.37–0.92, p = 0.020). According to protocol analysis which excluded
participants using the lotions less than 90% of the time found similar results with no effect from the use of repellent.
Conclusions: This randomised controlled trial suggests that topical repellents are not a suitable intervention in addition to
LLINs against malaria amongst agricultural populations in southern Lao PDR. These results are also likely to be applicable to
much of the Greater Mekong Sub-region.
Trial Registration: This trial is registered with ClinicalTrials.gov number NCT00938379.
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Introduction
At present global malaria prevention efforts are focused on the
distribution of long-lasting insecticidal nets (LLINs) and indoor
residual spraying [1]. LLINs are the current best practice and
protect from mosquito biting indoors at night, but where vectors
bite outdoors or early in the evening their effectiveness may be
reduced. The major Afro-tropical malaria vector Anopheles gambiae
typically feeds at night and indoors, making LLINs a perfect
intervention tool against this species. However the major vectors in
Southeast Asia and South America commonly feed outdoors [2–
4]. Also of concern is the threat of increased outdoor biting as a
result of either species shifts or behaviour change in response to
insecticide use [5–7]. Therefore there is a growing need for
intervention tools that can protect from outdoor biting.
Topical repellents have the potential to reduce vector contact in
this setting. Field trials in Thailand and Malaysia show di-ethyl-
N,N-toluamide (DEET) concentrations of 15–20% decrease
mosquito biting by over 83% [8–10]. However few trials have
been able to demonstrate an effect on malaria transmission by the
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use of insect repellent. On the Thai-Myanmar border, pregnant
women were given either thanaka (a traditional cosmetic derived
from Limonia acidissima) mixed with DEET or thanaka alone.
Although a 29% reduction in P. falciparum was observed, the
transmission level was too low for this to be statistically significant
[11]. Similarly, in Afghanistan low malaria rates meant a 45%
reduction in malaria (96% of cases were P. vivax) observed in
people using a repellent soap containing 20% DEET and 5%
permethrin was non-significant [12]. In Ecuador and Peru a
village randomised trial of repellent soap found no reduction in
malaria compared to untreated controls [13]. Nonetheless, a 56%
reduction in the odds of P. falciparum infection was found in
Pakistan amongst households using repellent soap compared to
those using a placebo, although no effect was found for P. vivax
infections [14]. Households using 30% p-Menthane-3,8-diol
(PMD, a repellent derived from lemon eucalyptus, Eucalyptus
maculata citriodon) in Bolivia had an 80% lower incidence of P. vivax
[15]. There was also an 82% reduction in P. falciparum but case
numbers were too low to reach significance. A number of common
problems have affected the results of these trials. Lower than
expected malaria rates have resulted in insufficient sample sizes
and non-significant reductions. Compliance is also very important,
since repellent requires application every few hours it is easy to
forget, lose and even apply in insufficient doses. The inconsistency
of these results means that it is not yet established whether the use
of insect repellent can reduce malaria infection.
The highest malaria incidence rates in Lao PDR are found in
Attapeu and Sekong provinces along the southern borders with
Cambodia and Vietnam [16]. Plasmodium falciparum causes almost
97% of cases and P. vivax the remainder [17]. Village based
surveys in Attapeu have found increased malaria risk to be
associated with sleeping without a bed net and visits to the forest
[18,19]. Unusually for Southeast Asia where young men are most
at risk of malaria infection, studies have not previously found a
gender bias in Lao PDR, although young children are the group
with the highest rates of malaria [18–20]. The main vector is
Anopheles dirus which is strongly associated with forests and is
frequently found biting outdoors [21,22]. Biting time varies
depending on sibling species, whilst for most peak biting occurs
from 21.00–02.00 h, other species start feeding at 18.00 h [21,23].
Anopheles minimus and An. maculatus are also important vectors and
are similarly found biting outdoors in the early evening [4,19,24–
26].
The aim of this trial was to determine whether using a topical
15% DEET repellent, established by landing catches to reduce
mosquito biting by 98.9%, would reduce malaria incidence against
exophagic vectors amongst rural populations in southern Lao
PDR using LLINs.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Study area
Attapeu and Sekong are the most south-eastern provinces in the
Lao PDR, sharing borders with Vietnam and Cambodia (Figure 1).
The Annamite mountains run along the eastern Vietnam border
and 60% of Attapeu Province is mountainous. The mountains are
covered with dense rainforest, contrasting with the open canopy
dry forest on the plains. The wet season is usually from April to
October, followed by a cool dry season from November to January
and a hot dry season from February to March. Rice farming is the
main economic activity with 57% of Attapeu’s population being
farmers and 71% in Sekong [27]. The malaria situation in Lao
PDR is similar to that across the mainland Southeast Asia; low
overall, but a severe problem in forested border areas. Within Lao
PDR, it is the southern provinces that are most affected by
malaria, with P. falciparum parasite rate in Attapeu and Sekong
about twice as high as the national average [27]. Plasmodium
falciparum is found in about 80% of cases, and P. vivax in most of the
rest [19,20,22,26]. The most important malaria vectors are An.
dirus, An. minimus and An. maculatus [25,28], and all feed early and
outside implying that they will be less affected by conventional
control methods such as LLINs [4,19,23,25,29–31]. However
although these behaviours may reduce the effectiveness of LLINs
in reducing malaria transmission, non-use of a bed net is still
associated with malaria in Lao PDR [18,19]. Current policy in the
country is for the entire population at risk (estimated to be 70% of
the country) to receive LLINs [17]. In addition free diagnosis and
treatment with artemisinin combined therapy (ACT) has been
implemented to poor populations. Resistance to artemisinin has
not yet been detected here [32].
Recruitment
Households were recruited from 126 villages; 72 in Attapeu
Province and 54 in Sekong Province. Participants were primarily
rural agricultural workers that often work and sleep overnight
away from the village during the wet season. Eligible households
needed five volunteers aged 6–60 years. Study households also had
Figure 1. Location of study villages in Attapeu and Sekong
provinces in Southern Lao PDR.
doi:10.1371/journal.pone.0070664.g001
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to be separated by at least 10 m to prevent diversion of biting from
repellent users to placebo users. District health staff obtained
written informed consent from all participants or the carers of
participants aged under 18 years. Baseline information was
collected on age, gender and household wealth indicators.
A household-cluster randomised design was chosen so that
members of the same household were assigned to the same
treatment. This avoided accidental mix-up of treatments, but also
prevented potential diversion of biting from repellent users to
placebo users in close proximity. This effect has been demon-
strated over 1 m and could lead to the overestimation of the
protection given by repellents [33]. The only reliable epidemio-
logical data from the study area prior to the start of the trial was
38% prevalence of P. falciparum from village surveys [34]. Previous
trials of topical repellent have shown an 80% reduction in clinical
malaria due to P. vivax and a 44% reduction in P. falciparum
infection [14,15]. A 50% reduction in clinical malaria was
therefore considered to represent a useful malaria intervention in
this setting. An initial sample size of 500 households per arm was
sufficient to detect a 50% reduction in clinical malaria associated
with repellent use at 90% power and 95% significance [35]. This
was based on an estimated pre-trial incidence of 2–6%. However,
a malaria incidence of only 0.7% was recorded in the first year of
data collection. Malaria cases also showed clustering at the village
level, but only one household had more than 1 case of P. falciparum
supporting the assumption that cases were not over-dispersed by
household. Therefore a coefficient of variation of 0.25 was used.
The spatial heterogeneity at village level howerer, underlined the
importance of stratifying randomisation by village. Sample sizes
were recalculated and a sample size of 633 households per arm
was found necessary to detect a 50% reduction in malaria
incidence with 95% level of significance at 80% power. This was
adjusted to approximately 800 households per arm to account for
non-compliance and loss to follow up.
Intervention
Households were randomised to one of the two treatment arms
using equal groups allocation which was stratified by village.
Heads of households picked treatment codes out of a bowl. A 15%
DEET lotion was provided to households in one treatment arm
and the remainder received a placebo lotion (both supplied by
SCJohnson, Racine, USA). Adult participants were provided with
three 100 ml bottles of lotion to last one month (approximately
10 ml per day). Children under 12 years were provided with two
bottles per month, corresponding to approximately 7 ml per day.
This amount was considered sufficient to apply the treatments to
arms and legs as demonstrated by trial staff. Participants were
instructed to use the lotion every evening. Full USA compliant
consumer product information were given verbally in the local
language. Any contraindications or side effects were recorded and
reported at each monthly follow-up for appropriate action to local
District Health departments.
Although previous repellent trials have used 20% DEET, a 15%
DEET formulation was selected because this was the lowest
concentration shown to be effective against mosquito biting in the
study area [36]. A low concentration was desirable to minimise the
possibility of adverse events in study subjects as the trial would
require them to use the repellent for up to nine months.
All study households were provided with sufficient LLINs
(PermaNetH2.0, deltamethrin 55 mg/m2, mesh 25 holes/cm2),
defined as one net for every 1.5 persons in the household, plus
another for use away from home. Participants were instructed to
sleep under a net every night, particularly when away from the
village. At monthly follow-up visits participants reported how
many nights they had slept under the nets in the village and also
when sleeping in the forest or rice fields.
Compliance was measured through self-reported use as nights
per month and proportion of lotion used estimated from returned
bottles. Random checks were carried out by trial staff to monitor
compliance, which involved visiting a village at dusk and smelling
the arms of participants to check lotion had been applied. To be
included in the according to protocol analysis a participant was
required to have used the lotion over 90% over the time: so self-
reported lotion use should be more than 27 evenings per month
and the volume of lotion used over 270 ml per month for adults
and 180 ml for children.
The repellent and placebo lotions were identified by 3-digit
codes as provided by the manufacturer. Participants, field staff
carrying out randomisation and follow-up surveys and trial staff
performing data entry and analysis were blinded for the length of
the trial. The trial was double-blinded and unblinding was only
carried out after data analysis was complete. However, the
possibility remains that participants were able to distinguish
between the active repellent and the placebo by the effect on biting
insects.
Follow-up surveys
All participants were tested by rapid diagnostic test (RDT:
CareStartTM Malaria Pf/Pv Combo test, AccessBio, NJ) every
month during active case detection. Follow-up surveys finished in
December in both years to ensure testing throughout the wet
season and into the following transition/dry season when previous
surveys had found high parasite rates [19]. All positive cases were
referred for immediate treatment following local guidelines
through the district health teams working on the study.
The primary outcome was malaria incidence measured by
monthly RDTs for P. falciparum and P. vivax. Positive RDTs, paired
with a negative RDT matched by age and village, were confirmed
by polymerase chain reaction at the London School of Hygiene &
Tropical Medicine.
Statistical analyses
The analytical plan was written prior to data collection. To
avoid the risk of including relapse infections, the plan was to only
include the first P. vivax positive result for each participant.
However, in the event no participants presented with multiple P.
vivax infections and all positive cases were therefore assumed to be
new infections. The low malaria rates also meant that the original
analysis using Poisson regression adjusted for repeated measures
and household clustered was unnecessarily complicated and a
simpler model chosen here.
An intention-to-treat analysis was performed on all data,
followed by a per protocol analysis which excluded participants
who slept under an LLIN and used the lotion in the evenings less
than 90% of the month. Subsidiary analyses were also carried out
at 75% and 50% compliance cut-offs. A principal component
analysis (PCA) using data on education, house construction
materials, type of electricity supply, ownership of motorbikes,
tractors and televisions and animal ownership was carried out to
establish overall socio-economic scores for each household. The
PCA scores along with the age, gender, nights slept under an
LLIN and nights spent away from the village were considered for
inclusion in the regression. All variables except treatment group
were first tested by non-parametric univariate methods and those
with a significant association with the outcome at p,0.2 were
considered for inclusion in the final model. Outcomes of time to
first malaria, P. falciparum and P. vivax infection were tested by
Mantel-Cox regression adjusted for intra-cluster household
Insect Repellents to Prevent Malaria
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variation by robust methods. Variables maintaining their associ-
ation in the multivariable model at p,0.05 were kept in the final
model. All analyses were carried out using STATA version 12
(Statcorp, Texas, USA).
Changes to trial design
Lower than expected malaria rates during the first year of the
trial led to a revision of the sample size required. Therefore 1300
households were recruited in the second year rather than the
previously planned 700. This increase meant the sideline
serological work on arbovirus infections had to be dropped due
to insufficient funding, and the trial focused solely on malaria
infections the major vector borne disease in the area.
Results
Baseline data
The first round of recruitment from 25th June to 4th July 2009
enrolled 300 households to the trial and a further 1,297
households were recruited between 24th April and 18th May
2010. A total of 7,980 participants were initially recruited but 40
(0.5%) were excluded after the baseline survey as they were outside
the 6–60 years age limit. Almost half of households (795, 49.8%)
were randomised to the repellent arm and the remaining 802
allocated to the placebo lotion. Baseline household-level socioeco-
nomic scores were derived from principle components analysis on
data about the occupation and education of household heads,
house construction materials, possessions and animal ownership.
Baseline malaria rates were slightly higher in the placebo group,
but not significantly so (Risk ratio: 0.82, 95% C.I. 0.5–1.37,
p = 0.454). Men had a slightly higher rate of malaria, but this did
not reach significance (parasite rate in females: 0.61%, in males:
0.83%, p= 0.263). Children aged 6–10 years had the highest
infection rates although differences were again not significant.
Overall, the households in the two treatment groups were very
similar despite wide variation between households (Table 1),
illustrating the success of the randomisation procedure.
Trial progress
Follow-up visits were carried out monthly, finishing in
December both years. However, no visits were made in September
2009 due to widespread flooding in the area, although households
did receive monthly lotion supplies. 7,980 people were enrolled to
the trial in June 2009 and April 2010. Forty participants were later
found to be outside the 6–60 year age limit and excluded and a
further 32 participants withdrew from the trial before follow-up.
Thus 7,908 participants were followed up for a total of 4,218
person-years giving an average follow-up of 6.4 months per
participant (Figure 2). Eighty-seven (1.1%) people experienced at
least one malaria episode (Table 2).
Compliance
Approximately 60% of participants self-reported full compli-
ance with lotion use each month with no difference between
treatment arms (repellent users 61.3%, placebo users 62.2%,
p= 0.104). Health staff also observed the volume of lotion that was
returned and found less than half of participants had used all the
lotion (repellent users 47.4%, placebo users 48.1%). A comparison
of full compliance from these two measures showed the false
positive rate, self-reported full compliance with non-lotion use was
46.7%, was much higher than the false negative rate, complete
lotion use with self-reported non-compliance 28.5% (Table 3).
The most common reason for non-compliance in both repellent
and placebo users was forgetting to use the lotion, although
allowing for household clustering there was no significant
difference between treatment arms (repellent users 68.8%, placebo
users 69.1%, p= 0.675). Other reasons for no compliance included
disliking the smell (repellent users 12.9%, placebo users 12.3%,
p= 0.212), and allergies which were slightly higher in repellent
users (repellent users 3.8%, placebo users 3.2%, p= 0.029).
Compliance with LLIN use was much higher than for lotion use
regardless of treatment group and accounting for household
clustering (repellent users 97.0%, placebo users 97.3%, p= 0.711).
But a relationship was found between compliance with LLIN use
and compliance with lotion use, and those participants who did
not sleep under their LLIN every night were much less likely to use
the lotion every day (x2 = 316.1, p,0.001).
Intention to treat analysis
Mean time to first malaria episode was 4.0 months (range: 0.9–
7.5) in the placebo group and 3.9 months (range: 0.7–7.5) in the
repellent group (Table 4). After accounting for socio-economic
score and gender, a Mantel-Cox comparison of the hazard ratio
found no difference between the two treatment groups (hazard
ratio: 1.00, 95% CI 0.989–1.014, p = 0.868). Similarly, no
differences were found between the two groups in terms of P.
falciparum (hazard ratio: 1.00, 95% CI 0.989–1.02, p = 0.641) and
P. vivax infection (hazard ratio: 1.00, 95% CI 0.979–1.02,
p = 0.904).
Table 1. Baseline characteristics of the study participants and households.
Repellent Placebo
% Participants female 55.3% 54.9%
Median age of participants in years (IQR) 19 (11–35) 20 (11–35)
Ethnicity by household: Lao 396 (12.1%) 396 (12.3%)
Katuic 712 (21.8%) 726 (22.5%)
Bahnaric-Khmer 2154 (66.0%) 2106 (65.2%)
Median household PCA1 score (IQR) 20.23 (21.14, 1.09) 20.23 (21.23, 1.24)
Median household PCA2 score (IQR) 20.07 (20.78, 0.66) 20.07 (20.89, 0.80)
Parasite rate (%) 0.68 0.83
Note: A Principal Components Analysis was used to combine social and economic data into two scores PCA1 and PCA2.
doi:10.1371/journal.pone.0070664.t001
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According to protocol analysis
According to protocol analyses including only those participants
who had both reported and observed compliance with lotion use
above 50%, 75% and 90% also found no effect on malaria from
the use of repellent (Table 5). A higher socio-economic score was
found to significantly reduce malaria risk (hazard ratio: 0.72, 95%
CI: 0.58–0.90, p = 0.004). Women were also found to have a
reduced risk of infection (hazard ratio: 0.59, 95% CI: 0.37–0.92,
p = 0.020).
Figure 2. Progress of households from recruitment to Intention to Treat (ITT) and According to Protocol (ATP) analysis.
doi:10.1371/journal.pone.0070664.g002
Table 2. Malaria cases in repellent and placebo users.
Repellent users Placebo users
Participants 3,947 3,961
Mean follow-up (months) 6.4 6.4
Malaria 45 42
P. falciparum 35 33
P. vivax 14 16
Mixed infections 4 7
doi:10.1371/journal.pone.0070664.t002
Insect Repellents to Prevent Malaria
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Discussion
Summary
A randomised placebo controlled trial of 15% DEET repellent
lotion used by agricultural communities in southern Lao PDR was
carried out over two wet seasons in 2009–2010. The trial was
powered to detect an intervention effect of 50% on malaria
incidence. No significant reduction in malaria incidence was found
from the use of the topical repellent.
The regression analysis identified socio-economic scores as
being the most important risk factors for malaria. This score was
derived from data on household possessions and house building
materials. An increase of 1 in this score could represent having a
tiled roof compared to a thatched one, ownership of 1.5 more
motorbikes or 1 more television and corresponded with a 20–45%
reduction in the risk of malaria. Although malaria researchers in
the Lao PDR have not previously looked for a link between
malaria risk and wealth, our results are consistent with the findings
of other studies where lower socio-economic status is associated
with increased malaria risk [37,38].
There was a sustained drop of over 50% in monthly malaria
prevalence from baseline when all households were provided with
LLINs. Although this effect could be a result of changes in malaria
as there was no control group, the fact that lower prevalences
continued to be recorded throughout the wet season when they
would have been expected to increase supports the view that
LLINs and repeated treatment of malaria patients was effective at
reducing overall malaria transmission. However, the baseline rates
in 2009 and 2010 were similar suggesting there had been no
overall drop in malaria in the area between the two years.
Limitations
The use of 15% DEET was chosen based on human landing
catches in a village in rural Lao PDR [36]. This meant that the
protection measured would accurately reflect the perception of
biting pressure experienced by the participants of the trial.
However the major malaria vectors in the area, An. minimus and
An. maculatus, were very rare in the pilot study, so the level of
protection by 15% DEET from these species was not tested.
Anophelines show less response to repellents than other genera,
including Stegomyia and Culex mosquitoes that made up the
majority of catches in the local area [39,40]. Therefore the
recorded 98.9% protection against biting from 15% DEET is
potentially an overestimate for the protection from malaria
vectors.
While this gap in the efficacy testing of the intervention should
be acknowledged, it is probably not as important as the variation
in the dosage of DEET applied to the skin that would result from
variation between user applications. A participant applying only
5 ml of the repellent lotion, would achieve the same DEET dosage
as 10 ml of a 7.5% DEET lotion. Even two participants applying
the same volume of lotion would end up with slightly different
dosages depending on their relative body surface area. This
variability is a major limitation with topical insect repellents as an
intervention tool, but this does not rule out other forms of repellent
such as impregnated fabrics that can be better standardised.
Our pilot study found a reduction in mosquito biting of over
95% when individuals used the trial repellent compared to the
placebo, indicating repellent users might easily be able to
distinguish which group they had been assigned to after a short
period of use. All households in one treatment arm from a
particular village withdrew from the trial after three months
because they believed they had the placebo rather than repellent
Table 3. Observed and self-reported lotion use per participant-month.
Observed lotion use per month
,100% 100% Total
Self-reported lotion use per month ,100% 14,122 (72.9%) 5,259 (27.1%) 19,381
100% 12,339 (39.1%) 18,949 (60.6%) 31,288
Total 26,461 (52.2%) 24,208 (47.8%) 50,669
doi:10.1371/journal.pone.0070664.t003
Table 4. Mean time in person-months to first malaria
infection in repellent and placebo users.
Repellent users Placebo users
Participants 45 42
Mean time to first malaria 3.9 4.0
Mean time to first P. falciparum 3.7 3.6
Mean time to first P. vivax 3.3 3.5
Mean time to first mixed infection 7.6 6.5
doi:10.1371/journal.pone.0070664.t004
Table 5. Risk ratios and significance of repellent use, gender
and socio-economic score for malaria infection in Mantel-Cox
regressions of participants who used lotion more than 50%,
75% and 90% of the time.
Model
50%
Compliance
75%
Compliance
90%
Compliance
Malaria Placebo Comparison
group
Comparison
group
Comparison
group
Repellent 1.00 (p = 0.641) 1.00 (p = 0.730) 0.98 (p = 0.121)
PCA1 0.82 (p = 0.117) - 0.59 (p = 0.084)
PCA2 - 1.31 (p = 0.039) -
Falciparum Placebo Comparison
group
Comparison
group
Comparison
group
Repellent 0.99 (p = 0.406) 1.00 (p = 0.712) 0.99 (p = 0.498)
Male Comparison
group
- -
Female 0.67 (p = 0.135) - -
PCA1 - - 0.59 (p = 0.062)
PCA2 - 1.39 (p = 0.028)
doi:10.1371/journal.pone.0070664.t005
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lotion, and unblinding found that they were correct. This meant
that although the allocation of treatments and analysis was carried
out blind, it is unlikely that all participants remained successfully
blinded throughout the trial. An alternative that could prevent the
two lotions being directly compared would be to assign separate
batch numbers to each household’s supply meaning there was no
easy way for participants to separate the two treatment groups.
This method was not implemented in this trial as distribution of
lotion was made each month by village health workers with limited
education and it was judged that the system should work as simply
as possible to avoid confusion.
In order to reduce the possibility of artificially increasing
malaria rates in the placebo group through diversion of biting
from repellent users, a maximum of 25% of any village were
recruited to the trial. However although all members of a
household were randomised to the same study arm, it was not
feasible to enforce repellent use by all members of a household at
all times. Therefore, diversion of mosquitoes from participants
using the repellent to participants within the same household not
using the repellent could increase malaria risk for those
individuals. Individual compliance could have a large impact on
this household randomised trial, and the ability to accurately
measure this could also have an important impact on the outcome.
Participants were not compelled to use repellent during this trial, a
demonstration of how much, where and when to apply the lotion
was given at the start of the trial. Participants self-reported the
number of evenings per month they used the lotion and as a
second measure the amount of lotion returned was recorded.
Random checks were also carried out in the evenings on a small
sample of villages. Self-reported data on compliance is notoriously
unreliable, so these data were verified by the volume of lotion
used, as reported by interviewers, in order to filter non-compliers
out of the ATP analysis. However uncertainty remained over the
actual daily use of the lotion, in particular whether all members of
a single household had used the lotion supplied equally.
A small number of RDT tests were verified by PCR and a single
false negative was recorded. This raises the possibility that some
infections were missed by the pLDH based tests used in this trial.
Sub-microscopic infections have been shown to be of greater
importance for malaria transmission in low-transmission settings
such as were found in southern Lao PDR [41]. It is therefore
recommended that future trials in this region should include PCR
analysis to ensure non-falciparum infections are not missed.
Compliance was lower in this trial than in previous repellent
trials. Self-reported and observed data gave estimates of full
compliance from 48–60%, other trials have reported compliance
levels from 68–98% [11,14,15]. This trial ran for a longer period
(8 months compared to an average 4–6 months) which may have
resulted in lower compliance, particularly in drier months with low
mosquito numbers. However no decline in compliance was seen in
this trial from month to month, and the length of the trial did not
obviously correlate with the compliance in other trials. One trial
did report compliance around 50%, but this was because not
enough repellent had been provided [13]. Mathematical model-
ling suggests that compliance would be the most important
influence on the success of repellent interventions, so this low level
of compliance may explain at least some of the lack of effect found
in our results [42].
This trial was focused on agricultural populations and the results
may not be applicable to one important malaria risk group within
the GMS. Forestry workers spend much more time in the forest
potentially without access to good healthcare, and live in more
temporary accommodation meaning they may be more exposed to
vector biting. They often come from elsewhere in the region and
their movement between endemic and non-endemic areas has
been linked to the spread of antimalarial resistance in the region
[16].
Conclusion
Southern Lao PDR shares similarities in malaria vectors,
environment and the human population with much of the GMS
and the results of this trial are likely to be applicable across this
region. Topical repellents are not likely to be a suitable
intervention for agricultural populations in this region already
using LLINs who require long-term protection throughout the wet
season.
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